Apr 06, 2026, 08:48 PM IST IST Divi's Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Mar 21, 2026, 09:47 PM IST IST Divi's Laboratories - Disclosure Under ...
Divi’s reported a 7/18% beat on Ebitda driven by sustained revenues as well as higher gross contribution. We adjust our FY21 revenues upwards but believe that further gains from the earlier capex ...
MUMBAI: Shares of Divi's Laboratories rose a little over 4% after the company announced 29.3% year-on-year rise in its consolidated net profit to Rs502.02 crore for the quarter ended March. At 12pm, ...
Motilal Oswal Financial Services raised the target price for Divi's Laboratories to Rs 3,900 after the company delivered a strong beat on earnings in 4QFY24, fueled by a revival in the Custom ...
Hosted on MSN
Divi’s Laboratories Q2 Results: Cons profit jumps 35% YoY to Rs 689 crore, revenue up 16%
Divi’s Laboratories on Friday reported a consolidated net profit attributable to the shareholders of the company at Rs 689 crore for the second quarter ended September 2025, a 35% year-on-year (YoY) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results